by Plus Therapeutics | Feb 1, 2025 | GBM, LM, PBC, Uncategorized
A Heartfelt Thank You to Our ReSPECT-GBM & ReSPECT-LM Clinical Trial Participants To every patient who has participated in the ReSPECT-GBM and ReSPECT-LM clinical trials: THANK YOU! 💙 Your courage and commitment are helping advance critical research for recurrent...
by Plus Therapeutics | Jan 21, 2025 | Uncategorized
Comprehensive Patient Guides for Rare Diseases Are you looking for reliable, in-depth information on rare cancers and brain tumors? Our patient guides provide essential insights tailored for cancer patients and caregivers. Each guide covers: ✅ Disease background –...
by Plus Therapeutics | Jan 16, 2025 | LM
ReSPECT-LM Clinical Trial: Now Featured on MBCBrainMets.org! 📢 Exciting news! The ReSPECT-LM Clinical Trial is now a featured clinical trial on MBCBrainMets.org, a trusted resource hub for breast cancer patients living with brain metastases. 🔎 Learn more about the...
by Plus Therapeutics | Jan 15, 2025 | Uncategorized
Stay Updated with Plus Therapeutics – Follow Us & Subscribe! Want the latest updates on Plus Therapeutics and cutting-edge industry news? Stay informed by following us on all our social media accounts and subscribing to our email newsletter! 🔹 Be the first to know...
by Plus Therapeutics | Jan 14, 2025 | GBM
ReSPECT-GBM Clinical Trial Update: Phase 2 Enrollment Now Open We are excited to announce that enrollment for the Phase 1 ReSPECT-GBM clinical trial is complete! We are actively enrolling patients for Phase 2 of the trial, which focuses on treating recurrent...
Recent Comments